Company overview
LUMITOS operates market-leading B2B portals and newsletters for the life sciences, pharmaceutical, laboratory, and analytical sectors, providing users with industry news, supplier directories, products, webinars, and background information. They offer online marketing services to suppliers, including company presentations, product showcases, catalogue displays, and ad campaigns to generate leads and reach global audiences. With portals like bionity.com, chemeurope.com, and analytica-world.com, LUMITOS supports strategic decisions for over 14 million users worldwide.
Lumitos is listed in the NovaPharmaNews Supplier Hub in the life-science supply chain serving United States & Americas. Core focus areas include lumitos, pharma suppliers, life sciences b2b, laboratory marketing, analytical portals.
Structured facts
- Website
- https://www.lumitos.com/de/
- Markets served
- United States & Americas
- Keywords
- lumitos, pharma suppliers, life sciences b2b, laboratory marketing, analytical portals
Products & technologies
Markets served
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Frequently asked questions
- What capabilities does LUMITOS offer for pharmaceutical suppliers?
- LUMITOS provides company presentations, product showcases, catalogue displays, webinars, white papers, and online marketing campaigns on portals like bionity.com and analytica-world.com to attract buyers in pharma and life sciences.
- What geographies does LUMITOS cover?
- LUMITOS serves a global audience of over 14 million users through multilingual portals including chemeurope.com, bionity.com, quimica.es, and analytica-world.com, with operations based in Berlin and Nuremberg, Germany.
- How does LUMITOS support regulatory or compliance needs in pharma?
- LUMITOS portals aggregate supplier information, products, and industry news for life sciences and pharma, enabling buyers to access verified B2B details without specifying direct regulatory services; focus is on marketing and lead generation.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
